Table 3.
Parameter | Control | Metformin | Sitagliptin | DOX | Metformin/DOX | Sitagliptin/DOX |
---|---|---|---|---|---|---|
COX-2 | 1.25 ± 0.42 | 1.50 ± 0.54 | 1.25 ± 0.23 | 3.75 ± 0.43a | 2.00 ± 0.32ab | 2.50 ± 0.58ab |
iNOS | 1.75 ± 0.28 | 1.50 ± 0.28 | 1.50 ± 0.28 | 3.50 ± 0.35a | 2.25 ± 0.36b | 2.75 ± 0.24ab |
Caspase-3 | 1.25 ± 0.35 | 1.00 ± 0.42 | 1.25 ± 0.36 | 3.75 ± 0.52a | 1.75 ± 0.25b | 2.25 ± 0.37ab |
Data were expressed as mean ± SEM of six observations.
aSignificantly different from control group (P < 0.05).
bSignificantly different from doxorubicin group (P < 0.05).